Transcatheter aortic valve replacement (TAVR) is a minimally invasive procedure used to replace damaged heart valves, ...

For patients with symptomatic aortic regurgitation at high surgical risk, a transcatheter aortic valve replacement system ...

The 24-month postprocedure risk of death or stroke was 13.7% in those who had delayed TAVI and who were diagnosed with acute valve syndrome at the time of aortic valve replacement (AVR ... patients ...

Patients who underwent transcatheter aortic valve replacement (TAVR ... patients have at least one year of follow-up after their procedure and 200 have about two years of follow-up.

TAVR, which involves threading a replacement valve through a catheter in the groin or chest, has emerged as the leading procedure for treating symptomatic severe aortic stenosis in the U.S ...

At 5 years, there was no difference in death or disabling stroke between transcatheter aortic valve replacement and surgery in patients at low surgical risk. Both groups had improvements in ...

The 8-year data may hold value for TAVI—the newest Sapien valve uses the same tissue—but many other variables differ.

Solo Pace announced today that it received FDA clearance for its SoloPace Control System for temporary pacing in TAVR ...

The material is employed in a range of Edwards’ surgical and transcatheter valves, including versions of the Inspiris, Mitris ...

Data shows, versus surgery, the Evolut™ transcatheter aortic valve replacement (TAVR) system delivers a numerically lower rate of all-cause mortality or disabling stroke at five years ...

For young Indians grappling with aortic valve disease, the Ross procedure offers a lifeline—one that restores vitality ...